Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors

NMR in Biomedicine

Volumn 11, Issue 4-5, 1998, Pages 192-200

  Preul, M C ^a,c   Caramanos, Z ^a   Leblanc, R ^a   Villemure, J G ^a   Arnold, D L ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Brain neoplasm; Diagnosis; Image guided neurosurgery; Magnetic resonance spectroscopy; Pattern recognition

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BRAIN BIOPSY; BRAIN TUMOR; CASE REPORT; DATA ANALYSIS; DISCRIMINANT ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; NEUROSURGERY; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOTAXIS;

AGED; BRAIN NEOPLASMS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PATTERN RECOGNITION, AUTOMATED; PREDICTIVE VALUE OF TESTS;

EID: 0031927632     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199806/08)11:4/5<192::AID-NBM535>3.0.CO;2-3     Document Type: Article

References (74)

1. Preul M. C., Caramanos Z. and Collins D. L. et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nature Med. 2, 323-325 (1996).
2. Preul M. C., Narayanan S. and Comeau R. et al. Intraoperative, interactive guidance of stereotactic brain tumor biopsy or resection using in vivo biochemical image - anatomical image integration. J. Neurosurg. 84, 344 (1996).
3. Preul M. C., Caramanos Z. and Leblanc R. et al. Improved stereotactic brain tumor biopsy or resection using in vivo biochemical imaging: accurate prediction of regional tissue chemicopathological characteristics leads to more accurate target planning. J. Neurosurg. 86, 361A-362A (1997).
4. Chandrosoma P. T. Pathologic evaluation of imaging directed stereotactic biopsy materials. In Malignant Cerebral Glioma, ed. by M. L. J. Apuzzo, pp. 129-140. American Association of Neurological Surgeons, Park Ridge, Illinois (1990).
5. Burger P. C. and Scheithauer B. W. Atlas of Tumor Pathology: Tumors of the Central Nervous System. DC:AFIP UAREP, Washington (1994).
6. Burger P. C., Scheithauer B. W. and Vogel F. S. Surgical Pathology of the Nervous System and its Coverings. 3rd Edn. Churchill Livingstone, New York (1991).
7. Russell D. S. and Rubinstein L. J. Pathology of Tumors of the Nervous System. 5th Edn, Williams & Wilkins, Baltimore (1989).
8. Hinton D. R. Growth factors and proliferation potential. In Benign Cerebral Glioma, ed. by M. L. J. Apuzzo, pp. 149-162. American Association of Neurological Surgeons, Park Ridge, Illinois (1995).
9. Burger P. C., Vogel F. S., Green S. B. and Strike T. A. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56, 1106-1111 (1985).
10. Cairncross J. G. and Laperriere N. J. Low-grade glioma. To treat or not to treat? Arch. Neurol. 46, 1238-1239 (1989).
11. Salcman M. Epidemiology and factors affecting survival. In Malignant Cerebral Glioma, ed. by M. L. J. Apuzzo, pp. 95-109. American Association of Neurological Surgeons, Park Ridge, Illinois (1990).
12. Apuzzo M. L. J. Commentary: epidemiology and data analysis. In Malignant Cerebral Glioma, ed. by M. L. J. Apuzzo, pp. 111. American Association of Neurological Surgeons, Park Ridge, Illinois (1990).
13. Nelson D. F., Nelson J. S., Davis D. R., Chang C. H., Griffin T. W. and Pajak T. F. Survival and prognosis of patients with astrocytoma with atypical or anaplastic features. J. Neurooncol. 3, 99-103 (1985).
14. Atlas S. W. Intraaxial brain tumors. In Magnetic Resonance Imaging of the Brain and Spine, ed. by S. W. Atlas, pp. 223-326. Raven, New York (1991).
15. Kondziolka D., Lunsford L. D. and Martinez A. J. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma (see comments). J. Neurosurg. 79, 533-536 (1993).
16. Preul M. C., Caramanos Z. and Shenouda G. et al. In vivo biochemical effects of Tamoxifen on recurrent malignant astrocytomas: characteristics of response and failure. J. Neurosurg. 84, 352A-353A (1996).
17. Segall H. D., Destian S., Nelson M. D., Zee C. S. and Ahmadi J. CT and MR imaging in malignant gliomas. In Malignant Cerebral Glioma, ed. by M. L J. Apuzzo, pp. 63-78. American Association of Neurological Surgoens, Park Ridge, Illinois (1990).
18. Apuzzo M. L. J. Imaging: definition of structure and limitation of techniques. In Malignant Cerebral Glioma, ed. by M. L. J. Apuzzo, pp. 91. American Association of Neurological Surgeons, Park Ridge, Illinois (1990).
19. Lunsford L. D. and Coffey R. J. Stereotactic surgery in the diagnosis and therapy of malignant intracranial gliomas. In Malignant Cerebral Glioma, ed. by M. L. J. Apuzzo, pp. 115-128. American Association of Neurological Surgeons, Park Ridge, Illinois (1990).
20. Apuzzo M. L. J. Commentary: the initial and subsequent surgical endeavors. In Malignant Cerebral Glioma, ed. by M. L. J. Apuzzo, pp. 155. American Association of Neurological Surgeons, Park Ridge, Illinois (1990).
21. Glantz M. J., Burger P. C. and Herndon J. E. et al. Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 41, 1741-1744 (1991).
22. Kelly P. J., Daumas-Duport C., Scheithauer B. W., Kall B. A. and Kispert D. B. Stereotactic histologic correlations of computed tomography - and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin. Proc. 62, 450-459 (1987).
23. Chin L. S., Zee C. S. and Apuzzo M. L. J. Special considerations in point stereotactic procedures. In Brain Surgery: Complication Avoidance and Management, ed. by M. L. J. Apuzzo, pp. 414-425. Churchill Livingstone, New York (1993).
24. Chandrasoma P. T. Problems relating to pathological interpretation in stereotactic biopsy procedures. In: Apuzzo M. L. J., ed. Brain Surgery: Complication Avoidance and Management. New York: Churchill Livingstone, 425-431 (1993).
25. Arnold D. L. and Matthews P. M. Practical aspects of clinical applications of MRS in the brain. In: Young I. R., Charles H. C. eds. MR Spectroscopy: Clinical Applications and Techniques. London: Martin Dunitz, 139-159 (1996).
26. Fulham M. J., Bizzi A. and Dietz M. J. et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 185, 675-686 (1992).
27. Furuya S., Naruse S., Ide M., Murakami K., Miyazaki T. and Yamamoto T. The clinical application of multi-voxel 1H-CSI (chemical shift imaging) in brain tumors in Japenese. Nippon Igaku Hoshasen Gakkai Zasshi 51, 836-838 (1991).
28. Segebarth C. M., Baleriaux D. F., Luyten P. R. and den Hollander J. A. Detection of metabolic heterogeneity of human intracranial tumors in vivo by 1H NMR spectroscopic imaging. Magn. Reson. Med. 13, 62-76 (1990).
29. Luyten P. R., Marien A. J. H. and Heindel W. et al. Metabolic imaging of patients with intracranial tumours 1H MR spectroscopic imaging and PET. Radiology 176, 791-799 (1990).
30. Alger J. R., Frank J. A. and Bizzi A. et al. Metabolism of human gliomas: assessment with H-1 spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 177, 633-641 (1990).
31. Tedeschi G., Bertolino A. and Righini A. et al. Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology 45, 1384-1391 (1995).
32. Preul M. C., Leblanc R., Caramanos Z., Kasrai R., Narayanan S. and Arnold D. L. Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change. Can. J. Neurolog. Sci. 25, 13-22 (1998).
33. Peeling J. and Sutherland G. High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn. Reson. Med. 24, 123-136 (1992).
34. Tedeschi G., Lundbom N. and Raman R. et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J. Neurosurg. 87, 516-524 (1997).
35. Cristensen H., Lour H. O., Clausen J. and Biering F. Phospholipids and glycolipids of tumours of the central nervous system. J. Neurochem. 12, 614-627 (1965).
36. Klein J., Koppen A., Loffelhoz K. and Schmitthenner J. Uptake and metabolism of choline by rat brain after acute choline administration. J. Neurochem. 58, 870-876 (1992).
37. Kauppinen R. A. and Williams S. R. Nuclear magnetic resonance spectroscopy studies of the brain. [Review]. Prog. Neurobiol. 44, 87-118 (1994).
38. Simmons M. L., Frondoza C. G. and Coyle J. T. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45, 37-45 (1991).
39. Urenjak J., Williams S. R., Gadian D. G. and Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J. Neurochem. 59, 55-61 (1992).
40. Brooks D. J. Studies on the transport of K+, glucose, and albumin across the blood-brain barrier in man using positron emission tomography. In: Carrier Mediated Transport of Solutes from Blood to Tissue, ed. by D. L. Yudilevich, G. E. Mann. pp. 195-202. New York: Longman, (1985).
41. DiChiro G. Brain imaging of glucose utilization in cerebral tumors. In: Brain Imaging and Brain Function, ed. by L. Sokoloff. pp. 185-197. New York: Raven (1985).
42. Herholz K., Heindel W. and Luyten P. R. et al. In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann. Neurol. 31, 319-327 (1992).
43. Kuesel A. C., Donnelly S. M., Halliday W., Sutherland G. R. and Smith I. C. Mobile lipids and metabolic heterogeneity of brain tumours as detectable by ex vivo 1H MR spectroscopy. NMR Biomed. 7, 172-180 (1994).
44. Kuesel A. C., Sutherland G. R., Halliday W. and Smith I. C. 1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR Biomed. 7, 149-155 (1994).
45. Negendank W. and Sauter R. Intratumoral lipids in 1H MRS in vivo in brain tumors: experience of the Siemens cooperative clinical trial. [Review]. Anticancer Res. 16, 1533-1538 (1996).
46. Behar K. L., Rothman D. L., Spencer D. D. and Petroff O. A. C. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn. Reson. Med. 32, 294-302 (1994).
47. Rutter A., Hugenholtz H., Saunders J. K. and Smith I. C. Classification of brain tumors by ex vivo 1H NMR spectroscopy. J. Neurochem. 64, 1655-1661 (1995).
48. Kinoshita Y., Kajiwara H., Yokota A. and Koga Y. Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. Neurosurgery 35, 606-13; (1994).
49. Negendank W. G., Sauter R. and Brown T. R. et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J. Neurosurg. 84, 449-458 (1996).
50. Demaerel P., Johannik K. and Van Hecke P. et al. Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J. Comput. Assist. Tomogr. 15, 67-76 (1991).
51. Gill S. S., Thomas D. G. and Van Bruggen N. et al. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J. Comput. Assist. Tomogr. 14, 497-504 (1990).
52. Alger J. R., Frank J. A. and Bizzi A. et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET (see comments). Radiology 177, 633-641 (1990).
53. 1H-MR spectroscopic imaging and feature space for spectral pattern recognition. In: Magnetic Resonance Scanning and Epilepsy, ed. by S. D. Shorvon, D. R. Fish, F. Andermann, G. M. Bydder and H. Stefan. pp. 299-313. New York: Plenum (1993).
54. Arnold D. L., Shoubridge E. A., Villemure J. G. and Feindel W. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading. NMR Biomed. 3, 184-189 (1990).
55. Ott D., Hennig J and Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 186, 745-752 (1993).
56. Henriksen O., Wieslander S., Gjerris F. and Jensen K. M. In vivo 1H-spectroscopy of human intracranial tumors at 1.5 tesla. Preliminary experience at a clinical installation. Acta Radiol. 32, 95-99 (1991).
57. Usenius J. P., Tuohimetsa S., Vainio P., Ala-Korpela M., Hiltunen Y. and Kauppinen R. Automated classification of human brain tumors by neural network analysis using in vivo 1H magnetic resonance spectroscopic metabolite phenotypes. Neuroreport 7, 1597-1600 (1996).
58. Hagberg G., Burlina A. P., Mader I., Roser W., Radue E. W. and Seelig J. In vivo proton MR spectroscopy of human gliomas: definition of metabolic corrdinates for multi-dimensional classification. Magn. Reson. Med. 34, 242-252 (1995).
59. Lachenbruch P. A. Discriminant Analysis. Hafner, New York (1975).
60. Hand D. J. Discrimination and Classification. Wiley, Chichester (1981).
61. Urenjak J., Williams S. R., Gadian D. G. and Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13, 981-989 (1993).
62. Zee C. S., Conti P., Destian S., Chen D. C. P., Petrus L. and Segall H. D. Imaging features of benign gliomas. In: Benign Cerebral Glioma, ed. by M. L. J. Apuzzo. pp. 247-274. American Association of Neurological Surgeons, Park Ridges, Illinois (1995).
63. Osborn A. Diagnostic Neuroradiology. Mosby-Year Book, St. Louis (1994).
64. Kazner E., Wende S., Grumme T., Stochdorph O., Felix R. and Claussen C. Computed Tomography and Magnetic Resonance Tomography of Intracranial Tumors. Springer, Berlin (1989).
65. Chamberlain M. C., Murovic J. A. and Levin V. A. Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas [published erratum appears in Neurology 1988 Nov;38(11):1816]. Neurology 38, 1371-1374 (1988).
66. Kelly P. J. Role of stereotaxis in the management of low-grade intracranial gliomas. In: Benign Cerebral Gliomas, ed. by M. L. J. Apuzzo. pp. 275-292. American Association of Neurological Surgeons, Park Ridge, Illinois (1995).
67. Heilbrun M. P., Brockmeyer D. and Sunderland P. Stereotactic surgery for mass lesions of the cranial vault. In: Brain Surgery: Complication Avoidance and Management, ed. by M. L. J. Apuzzo. pp. 390-405. New York: Churchill Livingstone (1993).
68. Linskey M. E. The developmental biology of glial cells and its relation to the study of glioma biology. In: Benign Cerebral Glioma, ed. by M. L. J. Apuzzo. pp. 13-54. American Association of Neurological Surgeons, Park Ridge, Illinois (1995).
69. Chen T. C., Hinton D. R. and Apuzzo M. L. J. Malignant progression in gliomas. In: Benign Cerebral Glioma, ed. by M. L. J. Apuzzo. pp. 181-188. American Association of Neurological Surgeons, Park Ridge, Illinois (1995).
70. Salcman M. The natural history of low-grade gliomas. In: Benign Cerebral Glioma, pp. 213-230. American Association of Neurological Surgeons, Park Ridge, Illinois (1995).
71. Tatter S. B., Wilson C. B. and Harsh IV G. R. Neuroepithelial tumors of the adult brain. In: Neurological Surgery: A Comprehensive Reference Guide to the Diagnosis and Management of Neurosurgical Problems, ed. by J. R. Youmans. pp. 2612-2684. Philadelphia, Saunders (1996).
72. Nelson J. S., Tsukada Y., Schoenfeld D., Fulling K., Lamarche J. and Peress N. Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer 52, 550-554 (1983).
73. Collins D. L., Neelin P., Peters T. M. and Evans A. C. Automatic 3-D intersubject registration of MR volumetric data in standardized Talairach space. Journal of Comput. Assist. Tomogr. 18, 192-205 (1994).
74. Collingnon A., Maes F., Delaere D., Vandermeulen D., Stuetens P. and Marchal G. Automated muli-modality image registration based on information theory. Proceedings of the Information Processing in Medical Imaging. pp 263-274 (1995).